The Legal Intelligencer | Commentary
By David G. Mandelbaum | May 13, 2024
Just as a lawyer must have a basic understanding of many things that may affect a client's business or activities, the lawyer also has to have a basic understanding of how a changing climate will have changing effects on clients
The Legal Intelligencer | Commentary
By Dallis Terc | May 10, 2024
Employers need to consider the processing times and plan accordingly until processing times improve.
The Legal Intelligencer | Commentary
By Jules Epstein | May 10, 2024
Lay witnesses may not cross a line and give testimony that is "based on scientific, technical, or other specialized knowledge within the scope of Rule 702." That's for experts, and with expert testimony comes discovery obligations such as reports and CVs.
The Legal Intelligencer | Commentary
By Samuel E. Cohen and Ryan P. Friel | May 10, 2024
Like many recent DOL rules related to retirement investing, the retirement security rule is polarizing and is sure to face significant legal challenges, including from the insurance industry to whom the rule applies a new, heightened duty.
The Legal Intelligencer | Commentary
By Patrick J. Smith and Deanna J. Lucci | May 9, 2024
Pennsylvania seeks to become the 25th state to legalize recreational cannabis for adult use and establish standards for, among other things, the marketing of cannabis facilities and products.
The Legal Intelligencer | Commentary
By Timothy J. Horstmann and Kenneth Stark | May 9, 2024
The grants are funded through the U.S. Treasury under the American Rescue Plan Act of 2021 (ARPA), which authorized the use of funds for broadband infrastructure projects targeted at unserved or underserved households and businesses. Combined with private matching funds, the awards will result in over $400 million of broadband projects throughout Pennsylvania.
The Legal Intelligencer | Commentary
By Edward Waddington and Jesse LaGrossa | May 9, 2024
The considerations for determining the financial loss in a federal criminal matter are analogous to those a practitioner may employ in other issues requiring measuring a financial loss (i.e., damages in civil litigation).
The Legal Intelligencer | Commentary
By Benjamin P. Sheppard | May 8, 2024
The judicial landscape, at both the state and federal levels, is tasked with determining the existence of a private cause of action under each state's medical cannabis statute. This determination hinges on whether the statute delegates enforcement responsibilities to a governmental entity, or if it lacks an independent mechanism for addressing employer violations.
The Legal Intelligencer | Commentary
By Rich Lee | May 8, 2024
For this month's feature, I had the pleasure of speaking with Robyn Weinstein, who has dedicated her career to the advancement and craft of conflict resolution.
The Legal Intelligencer | Commentary
By Tariq Naeem | May 7, 2024
Momentum has been gathering behind efforts to reclassify marijuana under the Controlled Substances Act (CSA). Regardless of how marijuana is rescheduled under federal law, the Food and Drug Administration (FDA) could consider medical marijuana products to be unapproved "new drugs" subject to regulation under the Food, Drug, and Cosmetic Act (FDCA).
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
DESCRIPTION: The Metropolitan Transportation Authority ( MTA ) hereby solicits proposals from law firms, including sole practitioners, to pr...
The Partners Group is currently recruiting a VP of Legal for our burgeoning client, a real estate investment firm in Atlanta, GA. The firm h...